Available Available by request, if patient can afford Rarely available Capecitabine Cisplatin Cytarabine Dactinomycin Daunorubicin Doxorubicin Etoposide Fluorouracil Folinic acid Hydroxyurea Melphalan Mercaptopurine Methotrexate Thioguanine Vincristine Bleomycin Carboplatin Dacarbazine Epirubicin…
© Springer International Publishing Switzerland 2015Jean-Pierre Droz, Bernard Carme, Pierre Couppié, Mathieu Nacher and Catherine Thiéblemont (eds.)Tropical Hemato-Oncology10.1007/978-3-319-18257-5_50 Cancer in Children Mhamed Harif1 and Jamila El Houdzi2 (1) Hematology/Oncology, Cheikh Khalifa Hospital, Casablanca, Morocco (2) Pediatric Hemato-Oncology Service, Marrakech Mohammed…
© Springer International Publishing Switzerland 2015Jean-Pierre Droz, Bernard Carme, Pierre Couppié, Mathieu Nacher and Catherine Thiéblemont (eds.)Tropical Hemato-Oncology10.1007/978-3-319-18257-5_48 Thyroid Cancer Michele Klain1 and Martin Schlumberger1, 2 (1) Gustave Roussy and University Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France…
Fig. 1 Pathophysiology in the subentities and variants of MCL. MCL regroups at least three diseases: the classical nodal MCL, the most common entity, the indolent leukemic/splenic MCL, and the…
Fig. 1 Distribution of gynaecological malignancies at Ibadan, Nigeria (Adapted with permission from Odukogbe et al. [4]) 2 Epidemiology Published rates of the diseases differ worldwide, being high in Asia,…
© Springer International Publishing Switzerland 2015Jean-Pierre Droz, Bernard Carme, Pierre Couppié, Mathieu Nacher and Catherine Thiéblemont (eds.)Tropical Hemato-Oncology10.1007/978-3-319-18257-5_45 Cancer of the Penis, Anus, and Vulva Jean-Philippe Spano1 , Laurence Moureau-Zabotto2, Mathieu Minsat2 and Laurent Quéro3 (1) Medical Oncology Department, University Hospital Pitié-Salpétrière,…
Fig. 1 Algorithm for Ovarian cancer management 6.1 Surgical Management In advanced ovarian cancer, the aim is to achieve optimal cytoreduction, currently defined as complete resection of all disease with…
Fig. 1 Comparison of liver cancer incidence in 2012 (Acknowledgment: adapted from IARC Globocan 2012) (a) and HBV chronic carriage prevalence in 2006 (Acknowledgment: adapted from Center for Disease Control…
